Previous 10 | Next 10 |
2023-11-30 07:08:39 ET More on Can-Fite Biopharma Can-Fite climbs on mid-stage data for liver cancer therapy Can-Fite Biopharma discloses $100M mixed shelf offering - filing Seeking Alpha’s Quant Rating on Can-Fite Biopharma Historical earnings data fo...
Advanced liver cancer patient in prior Phase II study remains cancer-free 6.9 years after starting treatment with Namodenoson Can-Fite BioPharma Ltd . (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address ...
2023-11-22 09:57:58 ET DENVER, Colo., Nov. 22, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; ESGL Holdings Ltd (NASDAQ: ESGL), SciSparc Ltd (NASDAQ: SPRC), Safety Shot Inc (NASDAQ: SHOT), PaxMedica Inc ...
PETACH TIKVA, Israel, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd . (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced the entry into a definitive...
2023-11-21 13:19:04 ET More on Can-Fite Biopharma Can-Fite Biopharma discloses $100M mixed shelf offering - filing Seeking Alpha’s Quant Rating on Can-Fite Biopharma Historical earnings data for Can-Fite Biopharma Financial information for Can-Fite Bio...
2023-11-21 13:10:50 ET DENVER, Colo., Nov. 20, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; ProKidney Corp (NASDAQ: PROK), Can Fite Biofarma Ltd (AMEX: CANF), Seres Therapeutics Inc (NASDAQ: MCR...
2023-11-21 10:05:00 ET DENVER, Colo., Nov. 21, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Anghami Inc (NASDAQ: ANGH), ABVC BioPharma Inc (NASDAQ: ABVC), Can Fite Biofarma Ltd (AMEX: CANF), Altamira T...
2023-11-21 09:59:42 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom Stocks to watch in the Health Care sector a...
Can-Fite BioPharma Ltd . (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced that a patient who participated in the Phase II Liver Cancer Study and was treated wi...
Company management updates about ongoing activities and progress Can-Fite BioPharma Ltd . (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today confirmed that a...
News, Short Squeeze, Breakout and More Instantly...
Can-Fite Biopharma Ltd Sponsored ADR Company Name:
CANF Stock Symbol:
NYSE Market:
Can-Fite Biopharma Ltd Sponsored ADR Website:
RAMAT GAN, Israel, July 17, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, invites investors to a webinar on August 8...
PETACH TIKVA, Israel, July 11, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced that it has submitted ...
Liver cirrhosis treatment global market is estimated to reach $29.2 billion by 2030 Ramat Gan, Israel, July 01, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that addr...